MBL77 OPTIONS

mutations specified the fact that, as defined down below, CLL therapy relies over the presence or absence of these mutations. The existing consensus is the fact that, other than clonal mutations, subclonal mutations with a variant allelic frequency starting from five to ten% (and so beneath the brink of detection by regular molecular tactics) is al